Search results
Results from the WOW.Com Content Network
Luspatercept, sold under the brand name Reblozyl, is a medication used for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. [ 5 ] The US Food and Drug Administration (FDA) considers it to be a first-in-class medication .
Inflammatory demyelinating diseases (IDDs), sometimes called Idiopathic (IIDDs) due to the unknown etiology of some of them, are a heterogenous group of demyelinating diseases - conditions that cause damage to myelin, the protective sheath of nerve fibers - that occur against the background of an acute or chronic inflammatory process.
A myelodysplastic syndrome (MDS) is one of a group of cancers in which blood cells in the bone marrow do not mature, and as a result, do not develop into healthy blood cells. [3] Early on, no symptoms typically are seen. [3] Later, symptoms may include fatigue, shortness of breath, bleeding disorders, anemia, or frequent infections. [3]
(Reuters) -The U.S. Food and Drug Administration's staff reviewers said on Tuesday they were unclear if Geron's blood disorder drug provided a clear benefit to patients in a late-stage trial and ...
“People with malabsorption in their stomach or intestines, such as patients after weight loss surgery or patients with gastrointestinal issues, need robust vitamin supplementation to maintain ...
Understanding what increases the risk of dementia can help doctors and policymakers identify people most at risk and provide the right support to slow down or lessen the impact of cognitive decline.
Chronic myelomonocytic leukemia (CMML) is a type of leukemia, which are cancers of the blood-forming cells of the bone marrow.In adults, blood cells are formed in the bone marrow, by a process that is known as haematopoiesis.
Get live expert help with your AOL needs—from email and passwords, technical questions, mobile email and more. AOL Mail for Verizon Customers AOL Mail welcomes Verizon customers to our safe and delightful email experience!